Please do not adjust margins
Organic & Biomolecular Chemistry
Page 4 of 4
DOI: 10.1039/C6OB00551A
COMMUNICATION
Journal Name
6
7
K. Shen, X. Liu, G. Wang, L. Lin and X. Feng, Angew. Chem.,
Int. Ed., 2011, 50, 4684.
(a) H. H. Jung, A. W. Buesking and J. A. Ellman, Org. Lett.,
2011, 13, 3912; (b) W. Yan, D. Wang, J. Feng, P. Li and R.
Wang, J. Org. Chem., 2012, 77, 3311; (c) A. Kumar, V. Sharma,
J. Kaur, V. Kumar, S. Mahajan, N. Kumar and S. S. Chimni,
Tetrahedron, 2014, 70, 7044; (d) J. George, B. Sridhar and B.
V. Reddy, Org. Biomol. Chem., 2014, 12, 1595; (e) T. Arai, K.
Tsuchiya and E. Matsumura, Org. Lett., 2015, 17, 2416; (f) S.
Nakamura, S. Takahashi, D. Nakane and H. Masuda, Org.
Lett., 2015, 17, 106; (g) C. Beceño, P. Chauhan, A. Rembiak, A.
Wang and D. Enders, Adv. Synth. Catal., 2015, 357, 672; (h) H.
Fig 4. The assumed transition state for the addition reaction of ketimines
Takada, N. Kumagai and M. Shibasaki, Org. Lett. , 2015, 17
,
4762; (i) Q. He, L. Wu, X. Kou, N. Butt, G. Yang and W. Zhang,
Org. Lett. , 2016, 18, 288.
(a) Y. L. Liu, F. Zhou, J. J. Cao, C. B. Ji, M. Ding and J. Zhou,
8
9
Based on the stereochemical outcome of the reaction, a
possible mechanism for the addition of allyltributyltin to the
ketimines derived from isatins is proposed (Figure 4). Initially,
Imidazolylpyridine-In(OTf)3 reacts with allyltributyltin to give
an allyl coordinated complex. On the other hand, through
coordination, the metal Indium holds it in close proximity with
the ketimines. Following an enantioselective addition of allyl to
ketamine from the Re-face, the (S) configured product was
obtained.
Org. Biomol. Chem., 2010,
F. G. Gatti, G. Lesma, T. Pilati and B. Trucchi, Org. Biomol.
Chem., 2011, , 5515; (c) D. Wang, J. Liang, J. Feng, K. Wang,
8, 3847; (b) A. Sacchetti, A. Silvani,
9
Q. Sun, L. Zhao, D. Li, W. Yan and R. Wang, Adv. Synth. Catal.,
2013, 355, 548; (d) Y. L. Liu and J. Zhou, Chem. Commun.,
2013, 49, 4421; (e) D. Chen and M. H. Xu, J. Org. Chem., 2014,
79, 7746.
(a) Q.-X. Guo, Y.-W. Liu, X.-C. Li, L.-Z. Zhong and Y.-G. Peng, J.
Org. Chem., 2012, 77, 3589; (b) W. Yan, D. Wang, J. Feng, P.
Li, D. Zhao and R. Wang, Org. Lett., 2012, 14, 2512; (c) X.
Chen, H. Chen, X. Ji, H. Jiang, Z.-J. Yao and H. Liu, Org. Lett.,
2013, 15, 1846; (d) X.-B. Wang, T.-Z. Li, F. Sha and X.-Y. Wu,
Eur. J. Org. Chem., 2014, 2014, 739; (e) O. D. Engl, S. P. Fritz
and H. Wennemers, Angew. Chem., Int. Ed., 2015, 54, 8193;
(f) T. Liu, W. Liu, X. Li, F. Peng and Z. Shao, J. Org. Chem.,
2015, 80, 4950; (g)N. Hara, S. Nakamura, M. Sano, R. Tamura,
Y. Funahashi and N. Shibata, Chem. Eur. J., 2012, 18, 9276; (h)
T.-Z. Li, X.-B. Wang, F. Sha and X.-Y. Wu, J. Org. Chem., 2014,
79, 4332.
Conclusions
In summary, we have presented an efficient protocol for the
asymmetric allylation of ketimines derived from isatins in the
presence of 2.5 mol% In(OTf)3 and imidazolylpyridine ligand.
This process was carried out under mild conditions and a
variety of 3-allyl 3-aminooxindoles bearing a quaternary
stereocenter were prepared in good yields with moderate to
excellent enantiomeric excess (up to 97% ee).
10 (a) M. Holmquist, G. Blay and J. R. Pedro, Chem. Commun. ,
2014, 50, 9309; (b) T. Arai, E. Matsumura and H. Masu, Org.
Lett., 2014, 16, 2768; (c) M. Holmquist, G. Blay , M. C. Muñoz
and J. R. Pedro, Adv. Synth. Catal., 2015, 357, 3857.
11 (a) J. Feng, W. Yan, D. Wang, P. Li, Q. Sun and R. Wang, Chem.
Commun., 2012, 48, 8003; (b) Z. Tang, Y. Shi, H. Mao, X. Zhu,
W. Li, Y. Cheng, W. H. Zheng and C. Zhu, Org. Biomol. Chem.,
2014, 12, 6085; (c) J. P. Chen, W. W. Chen, Y. Li and M. H. Xu,
Org. Biomol. Chem., 2015, 13, 3363.
12 F. Shi, G.-J. Xing, R.-Y. Zhu, W. Tan and S. Tu, Org. Lett., 2013,
15, 128.
13 J.-M. Huang, X.-X. Wang and Y. Dong, Angew. Chem., Int. Ed.
, 2011, 50, 924
14 (a) Z.-Y. Cao, Y. Zhang, C.-B. Ji and J. Zhou, Org. Lett., 2011,
13, 6398; (b) B. Alcaide, P. Almendros and C. Aragoncillo, Eur.
J. Org. Chem., 2010, 2845.
15 G. Lesma, T. Pilati, A. Sacchetti and A. Silvani, J. Org. Chem.,
2009, 74, 4537.
16 D. Chen and M. H. Xu, Chem. Commun., 2013, 49, 1327.
17 N. A. Aslam, S. A. Babu, S. Rani, S. Mahajan, J. Solanki, M.
Yasuda and A. Baba, Eur. J. Org. Chem., 2015, 4168.
18 S. Nakamura, K. Hyodo, M. Nakamura, D. Nakane and H.
Masuda, Chem. Eur. J., 2013, 19, 7304.
Notes and references
1
(a) M. Ochi, K. Kawasaki, H. Kataoka, Y. Uchio and H. Nishi,
Biochem. Biophys. Res. Commun., 2001, 283, 1118; (b) K.
Bernard, S. Bogliolo and J. Ehrenfeld, Br. J. Pharmacol., 2005,
144, 1037; (c) S. Crosignani, C. Jorand-Lebrun, P. Page, G.
Campbell, V. Colovray, M. Missotten, Y. Humbert, C. Cleva,
J.-F. Arrighi, M. Gaudet, Z. Johnson, P. Ferro and A. Chollet,
ACS Med. Chem. Lett., 2011, 2, 644; (d) M. Rottmann, C.
McNamara, B. K. S. Yeung, M. C. S. Lee, B. Zou, B. Russell, P.
Seitz, D. M. Plouffe, N. V. Dharia, J. Tan, S. B. Cohen, K. R.
Spencer, G. E. González-Páez, S. B. Lakshminarayana, A. Goh,
R. Suwanarusk, T. Jegla, E. K. Schmitt, H.-P. Beck, R. Brun, F.
Nosten, L. Renia, V. Dartois, T. H. Keller, D. A. Fidock, E. A.
Winzeler and T. T. Diagana, Science, 2010, 329, 1175; (e) R.
R. Kumar, S. Perumal, P. Senthilkumar, P. Yogeeswari and D.
Sriram, J. Med. Chem., 2008, 51, 5731.
19 T. Wang, X.-Q. Hao, J.-J. Huang, K. Wang, J.-F. Gong and M.-P.
Song, Organometallics, 2014, 33, 194.
2
(a) F. Zhou, Y. L. Liu and J. Zhou, Adv. Synth. Catal., 2010, 352
1381; (b) G. Mohammadi Ziarani, R. Moradi and N. Lashgari,
Tetrahedron: Asymmetry, 2015, 26, 517; (c) D. Cheng, Y.
,
Ishihara, B. Tan and C. F. Barbas, ACS Catal., 2014,
K. Shen, X. Liu, L. Lin and X. Feng, Chem. Sci., 2012,
Y. Wei, S. Wen, Z. Liu, X. Wu, B. Zeng and J. Ye, Org. Lett.,
2015, 17, 2732.
4
, 743.
3
4
3, 327.
5
Z. Yang, Z. Wang, S. Bai, K. Shen, D. Chen, X. Liu, L. Lin and X.
Feng, Chem. Eur. J., 2010, 16, 6632-6637.
4 | J. Name., 2012, 00, 1-3
This journal is © The Royal Society of Chemistry 20xx
Please do not adjust margins